Rare diseases
Investigational molecules
Locations
Back to Croatia85 clinical trials in Osijek, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
CroatiaStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
CroatiaComparison of two doses of cabozantinib (60 mg vs 140 mg) in patients with progressive metastatic medullary thyroid cancer
CroatiaStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
CroatiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
CroatiaStudy Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CroatiaStudy on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
CroatiaStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
CroatiaStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
CroatiaStudy on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease
CroatiaStudy of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa
CroatiaStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for psoriatic arthritis, systemic sclerosis, and Sjögren's Syndrome. Studies evaluate new therapeutic approaches targeting specific immune pathways.
Investigations include both biologic and non-biologic treatment options for patients with varying disease severity.
Comprehensive studies examining treatments for Crohn's Disease and Ulcerative Colitis. Research focuses on novel therapeutic compounds and combination treatments.
Trials aim to improve clinical outcomes and quality of life for patients with moderate to severe disease.
Advanced research into Multiple Sclerosis and tardive dyskinesia treatments. Studies evaluate new therapeutic approaches and compare treatment efficacy.
Focus on developing treatments that can slow disease progression and improve symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
